# Glox Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glox-therapeutics

- Industry: Biotechnology
- Headquarters: Glasgow, UK
- Website: www.gloxtherapeutics.com
- Total disclosed funding: $5.3M
- Latest round: Seed (Nov 14, 2023)
- Investors on record: 2

## About

Based in Glasgow, UK, and co-founded by Daniel Walker (CSO), Colin Kleanthous (Head of Scientific Advisory board), and James Clark (CEO)in 2023, Glox Therapeutics Limited operates as a biotechnology research company specializing in precision antibiotics. In November 2023, the firm raised GBP 4.3 million in seed funding co-led by investors Boehringer Ingelheim Venture and Scottish Enterprise.

The company, as of November 2023, is working on the development of engineered protein bacteriocins-based antibiotics targeting drug-resistant pathogenic bacteria. Glox offers a platform called Glox Discovery Platform which exploits protein bacteriocins from Gram-negative bacteria to create species-specific antibiotics, avoiding harm to the host microbiome. The platform as of November 2023, focuses on pathogens like Pseudomonas aeruginosa and Klebsiella pneumoniae, both on the WHO critical list, to address urgent needs, including ventilator-associated pneumonia. Some of the Glox’s Engineered protein bacteriocins include Glox001 and Glox002, which target P. aeruginosa in ventilator-associated pneumonia, to eliminate specific bacterial pathogens without affecting the normal microbiota.

The company plans to utilize November 2023 funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria, build laboratories in Oxford and Glasgow, UK, and hire additional talents to accelerate its bacteriocin development program.

## Funding rounds

- Seed, Nov 14, 2023, $5.3M — Boehringer Ingelheim Venture, Scottish Enterprise

## Investors

- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed